Vascular Stents Market is projected to grow at a CAGR of 6.35% through 2032, according to DelveInsight

According to data provided by the British Heart Foundation (2025), globally, around 640 million people are living with heart and circulatory diseases across the world. Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, the most commonly diagnosed worldwide, affects an estimated 200 million people globally. Approximately 110 million men and 80 million women were affected.
In 2024, the global market was valued at USD 11,232.93 million and is expected to reach USD 18,277.68 million by 2032, driven by the rising incidence of cardiovascular diseases and related risk factors such as diabetes, hypertension, and obesity. These conditions are significantly increasing the need for effective vascular interventions to restore and maintain proper blood flow.

Growing awareness of cardiovascular health, coupled with the expansion of screening and early diagnostic programs, is enabling timely detection and treatment of arterial blockages, thereby increasing the uptake of stenting procedures. Additionally, the surge in angioplasty procedures worldwide is directly contributing to the demand for vascular stents, which play a vital role in re-establishing normal circulation.

Furthermore, ongoing technological advancements and product innovations by leading manufacturers are enhancing clinical outcomes and expanding stent applications across a wider range of patient populations. Together, these developments are expected to accelerate the growth of the vascular stents market throughout the forecast period.

DelveInsight's Vascular Stents Market Insights report offers an in-depth assessment of current and forecasted market trends, along with analyses of competitive landscape, key drivers, challenges, barriers, and major companies shaping the global vascular stents market.

Request for a sample page report @ https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr

Key Takeaways from the Vascular Stents Market Report

The Vascular Stents market is expected to record steady growth from 2025 to 2032, expanding at a moderate CAGR over the forecast period.

According to DelveInsight, North America is projected to hold the largest share of the global Vascular Stents market, supported by advanced healthcare systems, high disease prevalence, and strong adoption of innovative interventional technologies.

Leading companies operating in the market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company, ENDOLOGIX LLC, Biosensors International Group, Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, and SCITECH, among others.

Recent key developments include:

*
June 2024: Royal Philips announced the first implantation of its Duo Venous Stent System following FDA Premarket Approval (PMA). The device is intended to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI).

*
January 2024: W. L. Gore & Associates, Inc. obtained FDA approval for its lower-profile GORE Registered VIABAHN Registered VBX Balloon Expandable Endoprosthesis (VBX Stent Graft), expanding available treatment options for complex vascular conditions.

*
January 2024: Reflow Medical, Inc. received CE Mark certification in the European Union for its Bare Temporary Spur Stent System, designed to treat de novo or restenotic lesions in the infrapopliteal arteries. When used with a drug-coated balloon (DCB), the device enhances drug uptake and therapeutic efficacy.

These technological advancements and regulatory milestones continue to strengthen innovation and drive growth within the vascular stents market globally.

To read more about the latest highlights related to the Vascular Stents market, get a snapshot of the key highlights entailed in the Global Vascular Stents Market Report [https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Vascular Stents Overview

Vascular stents are small, expandable mesh-like medical devices inserted into blood vessels to maintain vessel patency and ensure proper blood flow. They are commonly utilized in the management of coronary artery disease, peripheral artery disease, and other vascular obstructions caused by plaque buildup or thrombosis.

These stents are available in various forms, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable vascular scaffolds (BVS). Among them, DES are the most widely adopted, as they gradually release therapeutic agents that help prevent restenosis-the recurrence of vessel narrowing after the procedure.

By offering mechanical support to blood vessels and preventing collapse, vascular stents serve a crucial function in minimally invasive cardiovascular procedures like angioplasty, leading to better clinical outcomes, faster recovery, and a reduced likelihood of repeat interventions.

Vascular Stents Market Insights

North America is expected to command the largest share of the vascular stents market in 2024, maintaining its leadership position due to several contributing factors. The region's high burden of cardiovascular diseases, robust healthcare infrastructure, presence of leading market players, and swift adoption of advanced interventional technologies are key drivers of its dominance. Additionally, rising healthcare expenditure and supportive reimbursement frameworks continue to reinforce its strong market standing.

According to the Centers for Disease Control and Prevention (CDC, 2024), approximately 4.9% of U.S. adults were diagnosed with coronary heart disease in 2022, while an estimated 12.1 million Americans were projected to be living with atrial fibrillation by 2023. Each year, the U.S. records over 795,000 stroke cases, including about 610,000 first-time incidents and 185,000 recurrent cases-equivalent to one in four strokes occurring in individuals with a prior episode. The growing prevalence of obesity, hypertension, diabetes, and unhealthy lifestyle habits has intensified the incidence of coronary artery disease and stroke, fueling demand for interventional procedures like coronary angioplasty. As vascular stents are crucial for restoring and maintaining blood flow during these procedures, their utilization continues to rise across the region.

Moreover, public awareness initiatives in the U.S. are fostering early detection, preventive care, and timely treatment, further driving market growth. For instance, American Heart Month (February 2024), organized by the American Heart Association (AHA), emphasized cardiovascular health through Heart Walks, advocacy events, and lifestyle awareness campaigns, promoting preventive measures and greater acceptance of stenting interventions.

To know more about why North America is leading the market growth in the Vascular Stents market, get a snapshot of the Vascular Stents Market Outlook [https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Vascular Stents Market Dynamics

According to the British Heart Foundation (2025), approximately 640 million people worldwide are affected by heart and circulatory diseases. Among these, coronary (ischemic) heart disease is the most widespread, impacting nearly 200 million individuals globally, including about 110 million men and 80 million women.

The substantial global burden of ischemic heart disease is a major factor driving growth in the vascular stents market. This condition, caused by narrowing or blockage of the coronary arteries due to plaque buildup, restricts blood flow to the heart and can lead to angina, myocardial infarction, and other serious cardiac events. Vascular stents, particularly drug-eluting stents (DES), play a crucial role in managing this disease by restoring and maintaining arterial patency following angioplasty, making them a cornerstone in treatment and a key contributor to market expansion.

Supporting this trend, European Union (2024) statistics revealed that in 2022, the highest number of transluminal coronary angioplasty procedures per 100,000 population occurred in Croatia (500.1), Germany (379.3), and Bulgaria (378.4), while other EU nations reported rates between 156 and 342 per 100,000. As angioplasty remains a preferred minimally invasive treatment for obstructed or narrowed vessels, the use of stents-particularly drug-eluting and bioresorbable variants-has become essential to ensure long-term vessel openness and minimize restenosis risk.

Given the escalating global prevalence of cardiovascular diseases and the increasing adoption of angioplasty procedures, the demand for vascular stents is anticipated to grow substantially in the coming years.

Vascular Stents Market Drivers:

*
Rising cases of cardiovascular disorders and associated risk factors

*
Increasing awareness and screening programs

*
Rising number of angioplasty procedures globally

*
Increase in product development activities

Get a sneak peek at the Vascular Stents market dynamics [https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Scope of the Vascular Stents Market Report:

*
Coverage: Global

*
Study Period: 2022 to 2032

*
Key Vascular Stents Companies: Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and others.

Which MedTech key players in the Vascular Stents market are set to emerge as the trendsetter, explore @ Vascular Stents Companies [https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=vascular-stents-market-is-projected-to-grow-at-a-cagr-of-635-through-2032-according-to-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.